Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1160
-0.0039 (-3.25%)
At close: Oct 30, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $48.06 million as of October 30, 2026. It is the 30,281st most valuable company in the world and the 4,627th biggest in the United States. Its market cap has decreased by 72.54% in one year.
Market Cap
48.06M
Enterprise Value
39.80M
Revenue
34.56M
Global Rank
Country Rank
#4,627 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 48.06M, a decrease of -47.97%. That is a compound annual growth rate of -2.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 48.06M | -66.00% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 111.24M |
| Vaxart | 102.14M |
| ProText Mobility | 70.33M |
| Nuo Therapeutics | 61.51M |
| Arch Biopartners | 39.37M |
| Cell Source | 36.49M |
| ZIVO Bioscience | 33.71M |
| NDT Pharmaceuticals | 21.04M |